Patient Guide: A Study to Learn How Safe the Study Treatment BAY94-9027 is and How it Affects the Body in Previously Treated Children Aged 7 to Less Than 12 Years With Severe Hemophilia A, a Genetic Bleeding Disorder That is Caused by the Lack of a Protein Called Clotting Factor 8 (FVIII) in the Blood

We'll Help You Connect with This Trial

Quri.ai is a free clinical trial matching service. We help patients like you connect directly with research sites conducting this study.

  • Get matched to the right study location for you
  • Connect directly with study coordinators at 23 participating sites
  • Understand eligibility with our simplified screening tool
  • Free service - we're here to help you access clinical research
Trial ID: NCTNCT05147662
Status: COMPLETED
Condition: Treatment of Bleeding, Prophylaxis of Bleeding, Hemophilia A, Children
Phase: PHASE3

Find a Study Location Near You

This study is available at 23 research sites. We'll help you connect with the location that's right for you.

Participating sites include:
  • Orlando, Florida
  • La Plata, Buenos Aires
  • Buenos Aires, Ciudad Auton. De Buenos Aires
  • • And 20 more locations - let us help you find the closest one

Loading interactive enrollment tools...

The full interactive experience will load momentarily